Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Pathological mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a primary genetic cause of Parkinson's disease (PD).
• LRRK2 is linked to vesicle dynamics control through RAB protein phosphorylation, but mechanisms remain unclear.
• Previous work showed LRRK2 increases exocyst complex assembly via Sec8 interaction, mitigating PD effects in cells.

Purpose of the Study:

• To investigate the role of the exocyst complex in LRRK2-mediated Parkinson's disease pathogenesis.
• To determine if exocyst complex modulation can serve as a therapeutic strategy for PD.

Main Methods:

• Utilized LRRK2 Drosophila models to study exocyst complex assembly and RAB phosphorylation.
• Employed exocyst complex inhibition in cellular and Drosophila models to assess rescue of pathogenic phenotypes.
• Analyzed LRRK2 protein levels following prolonged exocyst inhibition.

Main Results:

• LRRK2-dependent exocyst complex assembly is downstream of RAB phosphorylation in Drosophila models.
• Exocyst complex inhibition rescued mutant LRRK2 pathogenic phenotypes in both cellular and Drosophila models.
• Sustained exocyst inhibition led to a significant decrease in LRRK2 protein levels.

Conclusions:

• The exocyst complex plays a crucial role in the LRRK2 pathway relevant to Parkinson's disease.
• Modulating the exocyst complex shows potential as a novel therapeutic target for Parkinson's disease.